Explore more
News
Sarepta shares rebound
Digest more
Sarepta Therapeutics’ stock was soaring Tuesday after the FDA recommended lifting the pause on the company’s Duchenne ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...
Novo Nordisk tapped Maziar Mike Doustdar, its head of international operations, as its new chief executive officer and ...
Sarepta Therapeutics failed to win the European drug regulator's backing for its muscle disorder gene therapy on Friday, as ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $100 million milestone payment from ...
The selloff came after the U.S. Food and Drug Administration said late Friday that it was probing the death of an 8-year-old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback